Investment Advisory Board - Dr. Bruce Robertson

Dr. Bruce Robertson
Managing Director, H.I.G Ventures
Investment Advisory Board – November 2003 to Present
GAP BioLife Investment Committee Member

Dr. Bruce Robertson is a managing director of H.I.G. Ventures and focuses on investment opportunities in the life sciences sector. He has extensive experience in life science investments and early stage investments in information technology and business services in the US, India, and China. Prior to his venture capital career, Robertson was Director of Business Development at IGEN International and a Research Manager at W.R. Grace & Co. He is on the boards of the Mid-Atlantic Venture Association, Shady Grove Hospital and the University of Delaware Research Foundation. Robertson has earned an MBA with High Distinction from Harvard Business School, a PhD in Chemical/Biomedical Engineering from the University of Delaware, and a BSE in Chemical Engineering and BA in Mathematics from the University of Pennsylvania.

GAP Fund I Highlights

Global Cell Solutions closed a Series A round on 4/22/08
SquareLoop closed a Series A round on 12/17/07
Tau closed a Series A round on 10/19/07
Verical closed a Series A round on 9/27/07
Plurapage closed a Series A round on 4/13/07
4FrontSecurity was acquired by Symantec on 2/23/07
Visure closed a Series A round on 2/22/07
RollStream closed a Series A round on 7/17/06
Paxfire closed a Series A round on 4/22/05